COVID-19 Volunteering in the U.S.
BI employees across the U.S. are out in their communities making a difference to help improve the lives of those who have been impacted by the coronavirus.
Search
What can the patient do?
Be aware and know your source.
The power of our people
Diversity & Inclusion is an integral part of Boehringer Ingelheim's identity; a key element of our culture. Click here to find out more information.
Kobe
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Kobe site.
Empowering all employees
Boehringer Ingelheim has been awarded as a Global Top Employer for the second year in succession. Find out more about why we are a Global Top Employer.
World Patient Safety Day 2021
As a sign of support for World Patient Safety Day, Boehringer Ingelheim lights up buildings in orange. Click here to learn and find out more.
COVID-19 Volunteering in Canada
Colleagues across Canada are doing their part during the pandemic by supporting their community’s needs. Click here to find out and learn more information.
Press Releases
Click here to find the latest press releases from Boehringer Ingelheim on animal health, prescription medicine, pipeline and corporate news.
COVID-19 Germany Together through the Pandemic
Boehringer Ingelheim enabled all 51,000 employees worldwide to take ten days off for voluntary work – with full payment. Click here to learn more.
COVID-19 Social distancing and pet care - A vet gives advice
We have asked Karsten Hesse, Technical Service Manager Pet at Boehringer Ingelheim from Germany, about the topic of social distancing and pet care.
Resizing our Carbon Footprint
The ecological balance of the world is at a tipping point. Thus, we step up the initiative “Carbon Footprint”. Click here to find out more information.
COVID-19 Boehringer Ingelheim Singapore JSS donations
Boehringer Ingelheim Singapore donates government payouts for more good causes, giving back to patients and animals who need it the most. Learn more.
COVID-19 General Q&A
Here we provide a list of questions and answers about COVID-19, including what it is, how it spreads, and more. Click here to find out more.
What is "Social Entrepreneurship?"
Our shared planet faces multiple threats, especially concerning people's health and wellbeing. Learn about how social entrepreneurship can help here.
Boosting performance with an inclusive performance culture
Inclusive leaders and an inclusive organisation allow diversity to flourish. Diversity is the mix. Inclusion is making the mix work. Learn more here.
New approaches in the battle against heartworm disease
Heartworm disease is a concern to dog and cat owners worldwide. Current disease control methods are increasingly challenged by drug resistance. Read more.
Yamagata
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Yamagata site.
COVID-19 USA U.S. employees show gratitude #foreachother
Employees across the U.S. display Boehringer Ingelheim’s culture of caring during this challenging time. Click here to find out and learn more.
COVID-19 Volunteering in Wuhan China
Boehringer Ingelheim is striving to support community residents and the Wuhan community during this epidemic. Click here to find out and learn more.
COVID-19 Boehringer Ingelheim Singapore charity donations
Find out how Boehringer Ingelheim Singapore is offering support for healthcare workers and vulnerable communities. Click here to learn more.
Travelling with dogs
What are some of the things we should consider when traveling with dogs? Click here to read our tips for a relaxing trip with your furry companion.
COVID-19 Volunteering in Australia and New Zealand
Our employees down under have embraced the opportunity to volunteer their time and skills as part of the company’s COVID-19 Global Support Program.
Duluth
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Duluth site.
COVID-19 USA Double the Impact in the Fight Against COVID-19
Employees can double their impact through the BI Cares Matching Gifts Program. Click here to learn and find out more information about this.
NexGard Spectra launched in China
Early August 2018, NexGard Spectra (afoxolaner and milbemycin oxime), the first oral endectocide for dogs, was launched in China. Click here to learn more.